Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Health tech Amid social distancing and other measures to help reduce the spread of coronavirus, digital therapeutics have come into sharper focus. (Image: Shutterstock)

Digital therapeutics are enjoying renewed attention amid the coronavirus crisis, and new industry analyses assert that health benefits managers and advisers might consider these prescription software alternatives as the cost of health care rises.

“Digital therapeutics are poised to change health care by allowing for the diagnosis, management, and treatment of medical conditions in a low-cost, scalable way,” the Boston-based tech advisory firm Lux Research said in a new analysis. “All health care stakeholders will be impacted by the adoption of this technology.”

Complete your profile to continue reading and get FREE access to BenefitsPRO.com, part of your ALM digital membership.

Your access to unlimited BenefitsPRO.com content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical BenefitsPRO.com information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com

Already have an account?



Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.